MED23 and lung adenocarcinoma: In a mouse model with Med23 depletion in T cells (Med23−/−), it is found a strong association between the decline of CD103+ T cells and spontaneous alveolar epithelial type II cell (AT2 cell)‐originated lung adenocarcinomas.